(Q74541056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Leishmania donovani

1 reference

A Ghosh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

W W Zhang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Matlashewski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

59-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Visceral leishmaniasis: more prevalent and more problematic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Visceral leishmaniasis in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Leishmania-HIV interaction: immunopathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3'-untranslated region

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Immune adherence-mediated opsonophagocytosis: the mechanism of Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Leishmania amazonensis: the phagocytosis of amastigotes by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900322-X

7 January 2021

10.1016/S0264-410X(01)00322-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11567746%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference